Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease
Trial ID: NCT05545826
Interventional - Phase Unknown - Not yet recruiting
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.
Conditions
Interventions
- Vibrotactile coordinated reset
Eligibility
Inclusion criteria
- Ages 18 and older
- 2. Idiopathic Parkinson's disease Hoehn and Yahr stage I
- 3. Fluent in English
- 4. Appropriate social support if required during an off state.
- 5. Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
- 6. Feels comfortable going off PD related medication during in person study visits
- 7. Lives in the United States
Exclusion criteria
- Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies
- 2. Any current drug or alcohol abuse.
- 3. Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
- 4. Pregnancy, breast-feeding or wanting to become pregnant
- 5. Physical limitations unrelated to PD that would affect motor ratings
- 6. Craniotomy
- 7. Brain surgery
- 8. Patient is unable to communicate properly with staff (i.e., severe speech problems)
- 9. Excessive drooling
- 10. A type of hair style that would impede the use of an EEG cap
- 11. Sensory abnormalities of the fingertips
- 12. Nasal dysfunction unrelated to smell loss
Sponsor
Stanford University
Source: Clinicaltrials.gov
Search more clinical trials on myTomorrows